Shenzhen News Network, February 2, 2024 (Reporter Gong Yuting Cheng Xi) In Pingshan, which focuses on the development direction of the three major industries of "smart cars, innovative drugs, and Chinese chips", the biomedical industry is the "mainstay" of the country. As an industry benchmark, Shenzhen Libang Precision Instrument Co., Ltd. (hereinafter referred to as "Libang") plays an important role in promoting the high-quality development of Pingshan industry. Recently, a reporter from Shenzhen News Network interviewed Zu Youdong, vice president of Lipon Group, to gain an in-depth understanding of Lipon's growth experience and development plan in Pingshan.
Pingshan is a hot land with great development potential and investment value.
As the core agglomeration area of Shenzhen's biomedical industry, Pingshan moved into Pingshan District as a whole in 2017 after the relocation of the group's ** chain, starting a new journey. Zu Youdong said: "Pingshan is a hot land with great development potential and great investment value. ”
As the core agglomeration area of Shenzhen's biomedical industry, Pingshan has cultivated an advanced manufacturing cluster of bio-industry focusing on biomedicine, high-end medical devices and health, attracting 1,115 biomedical enterprises to take root, with an average annual increase of more than 120 enterprises and an average annual output value growth rate of more than 20%.
Zu Youdong believes that Pingshan has provided strong support for the growth and development of Libang, and with the help of a relatively complete industrial chain, Libang has taken root in Pingshan, a fertile soil for the development of the biomedical industry, so that medical innovation achievements can benefit everyone.
Adhere to valuable innovation and develop in exploration.
Innovation is the driving force behind the past and the future, and clinical development is the original intention of every product. "Libon is committed to providing medical institutions with high-quality products and solutions close to clinical needs, covering six business segments: patient monitoring, electrocardiodiagnostics, ultrasound imaging, maternal and child health, in vitro diagnostics, and smart health. It is reported that Libon has launched China's first Windows system TCD, the first maternal fetal monitor, the first obstetric network monitoring system and the world's first magnetic fluorescence immunoassay analyzer and other products, constantly filling the gap in the medical field, providing products and services for more than 40,000 medical institutions, and the products are exported to more than 170 countries and regions.
In recent years, Libon has continuously invested in the field of medical artificial intelligence and made major breakthroughs, relying on big data and intelligent algorithms, Lipon Lingxi ultrasound integrated solution helps doctors to liberate some of the low value-added and high repetitive work, and improve the diagnostic efficiency and accuracy. Zu Youdong said that Lipon has always adhered to the concept of "first-class clinical, serving clinical", adhered to the core value of customer-oriented, constantly polished products and solutions that meet clinical needs, and made valuable innovations.
In the future, Lipon will also become a new cradle for exploring cutting-edge technologies, cultivating innovative talents in the industry, and a new engine for improving product development and production capabilities, laying a more solid foundation for making greater contributions to the development of Pingshan District.